Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race

Novartis has decided to dissolve its group that has been working on a cutting-edge therapy to treat cancer. In an internal email obtained by Endpoints, the head of the healthcare giant’s cell and gene therapies unit, Usman “Oz” Azam told the group that “things don’t always work out as envisioned.” Novartis spokeswoman Julie Masow confirmed […]